First Patent ApprovedHuLogix is pleased to announce on November 28, 2019 the application 16/419,983, patent for clinical weight loss in animals is complete and approved.
(Refer to patent page) The use of IgF-1 with Garcinol is a breakthrough in weight loss. This patent also has indications in diabetes management. "We are very excited to have our drug approved. I look forward to the clinical trials in 2020, as well as the additional drugs HuLogix currently has in the patent processing stage." CEO Martina Leon states. 
Americans spend more money on their pets in 2018 then Facebook made in as revenues. Companion animal pharmaceutical sales topped $21billion in 2018 and has maintained a steady annual increase. According to Psychology Today, "there are over 86 million owned cats and 78 million dogs in the US. 39% of all American households own a dog compared to 33% of American households with cats". "Both dog and cat owners seem to have strong feelings about their pets and report that they are considered to be "part of the family" (79% of dog owners and 63% of cat owners). Nonetheless, less than 1% of households cover their animals with pet insurance. By the way, there are more than 54 thousand veterinarians in the U.S. which is a 55% increase from 15 years ago". According to a survey by the American Pet Products Association, U.S. pet owners spent US$69.51 billion on pet products in 2017. Food $29.1b Vet care $17.1b Supplies and over-the-counter medicine $15.1b Pet services: grooming and boarding $6.2b Live animal purchases $2.1b Chart: The Conversation, CC-BY-ND Source: American Pet Products Association Get the data |
Hulogix staff is dedicated on focusing on the epigenetic mechanisms of disease in companion animal medicine. Hulogix is going beyond the cusp and into the new and powerful field of medicine that will have a huge impact on how we treat disease in the future. We thrive to develop agents that correct these aberrant disease processes on a genetic cellular level. HuLogix will always maintain the highest of standards and dedication to our goals. We will continue to be compliant in ALL aspects of the company while focused on the future. HuLogix is designed for the health and well being of every companion animal. We look forward to the development of new and innovated pharmaceuticals, treatments therapies, as well as DME Equipment for companion animals. "We are so excited for the future and the future is now." Martina Leon CEO
|
Disclaimer
The contents of this web site, such as graphics, clinical information, tweets, and/or documents is for informational purposes only and does not replace professional treatment. There is nothing on this web site to constitute medical advice for human or companion animals. This website is not intended as a treatment for any medical diagnoses. If you or your companion animal has a medical condition please consult a licensed physician and/or veterinarian. Always consult with the appropriate professional for specific advice related to any medical condition. Note; that while every attempt was made to insure all information within is accurate, errors or omissions may be contained therein, for which any liability is disclaimed.